P F
Apr 1, 2021

Commercial MDR Drugs requiring step-therapy 4/1/21

The following Commercial MDR drugs will require step therapy through a biosimilar effective 4/1/21:

Avastin

Herceptin

Rituxan

Neulasta

Neupogen